<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1209222598
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Hi-Alfa SR
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALFUZOSIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        79.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aurobindo Pharma Limited Unit III" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Limited Unit III
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 3103]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G04CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Hi-Alfa SR belongs to a group of medicines called alpha-1-blockers.<br />Hi-Alfa SR is used to treat moderate to severe symptoms of Benign Prostate Hyperplasia.</p><p dir="ltr">This is a condition where the prostate gland enlarges<br />(hyperplasia), but the growth in itself is not cancerous (benign). It occurs<br />most often in older men.<br />The prostate gland is situated under the bladder surrounding the urethra (the<br />tube that takes your urine to the outside of the body). With age, the prostate<br />gland may grow and press the urethra making it smaller. This may cause<br />problems with urination such as frequent urination and difficulty in passing urine.<br />Hi-Alfa SR works by relaxing the prostate gland muscle. This reduces the<br />narrowing of the urethra and so makes it easier to pass urine.<br />In a few patients with benign prostatic hypertrophy, the prostate gland gets<br />so big that it stops the flow of urine completely. This is called Acute Urinary<br />Retention.<br />&bull; This is very painful and you may need a short stay in hospital<br />&bull; A thin, flexible tube [catheter] is passed into the bladder. This drains the<br />water and relieves the pain.<br />&bull; During this time, Hi-Alfa SR 10mg Prolonged Release Tablets may be<br />used to help the water to flow again. This has only been shown to help<br />in men aged over 65.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Do not take Hi-Alfa SR</strong><br />- if you are allergic to alfuzosin or the other ingredients of this medicine<br />(listed in section 6). Symptoms of an allergic reaction include: a rash,<br />swelling of your lips, throat, or tongue, difficulty in swallowing or breathing.<br />- If you are allergic (hypersensitive) to alfuzosin-equivalent substances<br />(such as terazosin, doxazosin).<br />If you have, or have had in the past, low blood pressure when standing<br />up from a sitting or lying position (the medical term for this is orthostatic<br />hypotension). It can make you feel dizzy, light-headed or faint when<br />you stand or sit up quickly.<br />- If you are already taking another alpha-1-blocker (such as terazosin,<br />doxazosin). See section below on &lsquo;Other medicines and Hi-Alfa SR .In<br />case of doubt please ask your pharmacist or doctor.<br />- If you have liver problems.<br /><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Hi-Alfa SR if:<br />- You have severe kidney problems.<br />- You have a heart disease.<br />- You have chest pain (angina).<br />- You are known to have an abnormality of electrocardiogram (ECG),<br />called &ldquo;QT prolongation&rdquo;<br />- You ever get painful erections of the penis, unrelated to sexual activity<br />that will not go away, before or during treatment.<br />Do not take Hi-Alfa SR if you are taking:<br />&bull; Other alpha-blockers such as doxazosin, indoramin, prazosin,<br />terazosin, tamsulosin or phenoxybenzamine.<br />Check with your doctor or pharmacist before taking your medicine if:<br />&bull; In the past, you have had a large fall in blood pressure while taking an<br />alpha-blocker (this could include previous use of alfuzosin). See<br />paragraph immediately above for examples of other alpha-blockers.<br />&bull; You are taking a medicine for high blood pressure, as you may get<br />dizzy, weak or start sweating within a few hours of taking this medicine.<br />If this happens, lie down until the symptoms have completely gone. Tell<br />your doctor as the dose of your medicine may be changed.<br />&bull; You are taking medicines for chest pain or angina (nitrates).<br />&bull; You are taking medicines for fungal infections (such as ketoconazole,<br />itraconazole).<br />&bull; You are taking medicines for HIV (such as ritonavir).<br />&bull; You are taking medicines for bacterial infections (such as clarithromycin,<br />telithromycin).<br />&bull; You are taking medicines for treatment of depression (such as nefazodone).<br /><strong>Operations while taking Hi-Alfa SR</strong><br />&bull; If you are going to have an operation that needs a general anaesthetic,<br />tell your doctor you are taking Hi-Alfa SR before the operation. This is<br />because it can be dangerous as it can lower your blood pressure.<br />&bull; If you are undergoing eye surgery because of cataract (cloudiness of<br />the lens) please inform your eye specialist before the operation that<br />you are using or have previously used Hi-Alfa SR. This is because<br />Hi-Alfa SR may cause complications during the surgery which can be<br />managed if your specialist is prepared in advance.<br /><strong>Hi-Alfa SR with food and drink and alcohol</strong><br />- Take Hi-Alfa SR after a meal.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />As Hi-Alfa SR is not used in women, this section does not apply.<br /><strong>Driving and using machines</strong><br />You may feel dizzy and weak while taking Hi-Alfa SR. Adverse reactions<br />such as dizziness and asthenia may occur essentially at the beginning of<br />treatment. If this happens do not drive or operate any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor or pharmacist has told<br />you. Check with your doctor or pharmacist if you are not sure.<br />&bull; Swallow your tablets whole with plenty a fluid (for instance a glass of water).<br />&bull; Do not break, crush or chew your tablets. This can affect the release of<br />your medicine into the body<br />&bull; Take this medicine after a meal<br />&bull; The first dose should be taken at bedtime.<br />Use in children<br />Hi-Alfa SR is not recommended for children.<br />Adults:<br />The usual dose is one Hi-Alfa SR 10 mg Prolonged release tablet once a day.<br />Older patients (&gt; 65 years):<br />The usual dose is one Hi-Alfa SR 10 mg prolonged release tablet once a<br />day. The dose does not need to be adjusted for elderly (over 65 years).<br />Patients with mild to moderate kidney problems<br />Your dose does not need to be adjusted for mild to moderate kidney problems.<br /><strong>If you take more Hi-Alfa SR than you should</strong><br />Contact your doctor or your local hospital Accident and Emergency department<br />straight away. Tell the doctor how many tablets you have taken. Lie down as<br />much as possible to help stop the side effects. Do not try to drive to the<br />hospital yourself.</p><p dir="ltr"><strong>If you forget to take Hi-Alfa SR</strong><br />Do not take a double dose to make up for a forgotten dose. Skip the<br />missed dose and take the next tablet as directed<br /><strong>If you stop taking Hi-Alfa SR</strong><br />Keep taking your tablets, even if your symptoms improve. Only stop if your<br />doctor tells you to. The symptoms are better controlled if you continue<br />taking the same dose of this medicine.<br />If you have any further questions on the use of this medicine, ask your<br />doctor or pharmacist.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not<br />everybody gets them.<br />Chest pain (angina)<br />Normally, this only happens if you have had angina before. If you get<br />chest pain stop taking your tablets and contact a doctor or go to a<br />hospital immediately. This happens in less than 1 in 10,000 people.<br />Allergic reactions<br />You could notice symptoms of angioedema, such as a red and lumpy skin<br />rash, swelling (on the eyelids, face, lips, mouth and tongue), difficulty<br />breathing or swallowing.<br />These are symptoms of an allergic reaction.<br />If this happens, stop taking your tablets and contact a doctor or go to<br />a hospital immediately. This happens in less than 1 in 10,000 people.<br />Other side effects include:<br />Common (may affect up to 1 in 10 people)<br />&bull; Feeling dizzy<br />&bull; Headache<br />&bull; Feeling sick (nausea)<br />&bull; Stomach pain<br />&bull; Weakness or tiredness<br />Uncommon (may affect up to 1 in 100 people)<br />&bull; Feeling dizzy, lightheaded, or faint when you stand or sit up quickly.<br />&bull; Fast heart beat (tachycardia)<br />&bull; Chest pain<br />&bull; Runny nose, itching, sneezing, and stuffy nose.<br />&bull; Diarrhoea<br />&bull; Rashes and itching<br />&bull; Water retention (may cause swollen arms or legs)<br />&bull; Hot flushes.<br />Very rare (may affect up to 1 in 10,000 people):<br />&bull; Hepatotoxicity<br />Additional side effects (frequency not known) which may occur are:<br />If you are having an operation on your eyes because of cataracts (where<br />the lens of the eye is cloudy), the pupil may dilate poorly and the iris<br />(the coloured part of the eye) may become floppy during the procedure.<br />&bull; Irregular and fast heart beat<br />&bull; Decrease in white blood cells (neutropenia). Signs may include more<br />frequent infections, sore throat or mouth ulcers.<br />Increased risk of bleeding (including nose bleeds and/or bleeding<br />gums) and bruising. This could be a blood problem called<br />&lsquo;thrombocytopenia&rsquo; which is a reduced number of platelets in the blood.<br />&bull; Abnormal liver function (liver problem). Signs may include yellowing of<br />your skin or the whites of your eyes.<br />&bull; If you are undergoing eye surgery because of cataract (cloudiness of<br />the lens) and are using or have previously used Zochek, the pupil may<br />dilate poorly and the iris (the coloured circular part of the eye) may<br />become floppy during the procedure. This only occurs during the<br />operation and it is important for the eye specialist to be aware of this<br />possibility as the operation may need to be performed differently.<br />&bull; Abnormal, often painful, persistent erection of the penis unrelated to<br />sexual activity (priapism).<br />&bull; Being sick (vomiting).<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist. This includes<br />any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the label,<br />carton, bottle after (EXP).The expiry date refers to the last day of that month.<br />Store below 30C.<br />Do not throw away any medicines via wastewater or household waste. Ask<br />your pharmacist how to throw away medicines you no longer use. These<br />measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The active substance is Alfuzosin Hydrochloride.<br />Each prolonged release tablet contains Alfuzosin Hydrochloride Ph Eur. 10 mg<br />The other ingredients are:<br />Tablet core: Hypromellose (Methocel K100 MCR), Hydrogenated<br />Vegetable Oil, Povidone, Calcium Hydrogen Phosphate, Anhydrous,<br />Carbomer, Silica Colloidal Anhydrous, Magnesium stearate.<br />Tablet coating:<br />Hypromellose (Methocel E5 LV), Propylene Glycol, Titanium Dioxide and<br />Purified Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                White to off-white, round, biconvex, film-coated tablets, debossed with
‘X’ on one side and ‘47’ on other side.
Hi-Alfa SR 10 mg tablets are supplied in 30’s pack (10’s Blister x 3).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Manufacturer:</strong><br />Aurobindo Pharma Limited (Unit-III),<br />Survey No. 313 &amp; 314,<br />Bachupally, Bachupally Mandal,<br />Medchal-Malkajgiri District,<br />Telangana State, India.<br /><strong>Marketing Authorization Holder:</strong><br />Aurobindo Pharma Saudi Arabia Limited,<br />Jeddah, Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02/2022.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ينتمي هاي آلفا إس آر لمجموعة من الأدوية تُسمى كابحات ألفا- 1<br />يُستخدم هاي آلفا إس آر لعلاج أعراض فرط تنسج البروستاتا الحميد المتوسطة إلى الحادة. وهي حالة تتضخم<br />فيها البروستاتا (&nbsp;فرط تنسج)، ولكن النمو لا يكون سرطانيًا (&nbsp;حميد). وتحدث غالبًا لدي الرجال كبار السن.<br />تقع غدة البروستاتا تحت المثانة وتُحيط بالإحليل (الأنبوب الذي يأخذ البول لخارج الجسم). ومع تقدم العمر، قد<br />تنمو البروستاتا وتضغط على الإحليل متسببة في ضيقه. ذلك قد يتسبب في مشاكل بالتبول مثل التبول المتكرر<br />وصعوبة التبول.<br />يعمل هاي آلفا إس آر عبر بسط عضلة غدة البروستاتا، وبالتالي يُخفض من ضيق الإحليل ويجعل التبول أسهل.<br />في عدد قليل من المرضى الذين يعانون من تضخم البروستاتا الحميد ، تصبح غدة البروستاتا كبيرة لدرجة أنها<br />توقف تدفق البول تماما. وهذا ما يسمى الاحتباس البولي الحاد.<br />&bull; هذا مؤلم جدا وقد تحتاج إلى إقامة قصيرة في المستشفى<br />&bull; يتم تمرير أنبوب رفيع ومرن ] قسطرة [إلى المثانة. هذا يساعد في استخراج الماء ويخفف الألم.<br />&bull; خلال هذا الوقت، يمكن استخدام أقراص الإصدار ممتد المفعول هاي آلفا إس آر 10 مجم لمساعدة المياه<br />على التدفق مرة أخرى. وقد ثبت أن هذا يساعد فقط في الرجال الذين تزيد أعمارهم عن 65 عاما.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تأخذ هاي آلفا إس آر</strong><br />&minus; إذا كنت تعاني من حساسية تجاه ألفوزوسين أو أي من المكونات الأخرى لهذا الدواء ) المذكورة في<br />(القسم 6). أعراض التفاعلات التحسسية تتضمن: طفح، تورم بالشفتين أو العنق أو اللسان، صعوبة في<br />البلع أو التنفس.<br />&minus; إن كنت تعاني من حساسية (مُفرط التحسس) تجاه المواد المكافئة لألفوزوسين ( مثل تيرازوسين<br />ودوكسازوسين).<br />&minus; إن كنت تعاني أو عانيت من قبل من انخفاض ضغط الدم عند الوقوف من وضع الاستلقاء ( المصطلح<br />الطبي لذلك هو انخفاض ضغط الدم الانتصابي). قد يجعلك ذلك تشعر بالدوخة أو الصداع أو الإغماء عند<br />الوقوف أو الجلوس بسرعة.<br />&minus; إن كنت تأخذ بالفعل كابح ألفا- 1 آخر ( مثل تيرازوسين ودوكسازوسين). انظر القسم أدناه حول &quot;الأدوية<br />الأخرى وهاي آلفا إس آر. وفي حالة الشك يُرجى سؤال الصيدلي أو الطبيب.<br />&minus; إن كنت تُعاني من مشاكل بالكبد.<br /><strong>التحذيرات والاحتياطات</strong><br />تحدث مع طبيبك أو الصيدلي قبل أخذ هاي آلفا إس آر:<br />&minus; إن كنت تعاني من مشاكل كلوية حادة.<br />&minus; إن كنت مصابًا بمرض بالقلب.<br />&minus; إن كنت مصابًا بألم في الصدر ( ذبحة).<br />&rdquo;QT يُسمى &ldquo;استطالة موجات ) ECG( &minus; إن كان معروفًا إصابتك بشذوذ برسم القلب الكهربائي<br />&minus; إن كنت تعاني من انتصابات مؤلمة بالقضيب لا تزول ولا تتعلق بالنشاط الجنسي، وذلك قبل أو أثناء العلاج.<br />لا تأخذ هاي آلفا إس آر إن كنت تأخذ:<br />&bull; مثبطات ألفا أخرى مثل دوكسازوسين أو إندورامين أو برازوسين أو تيرازوسين أو تامسولوسين أو<br />فينوكسي بنزامين.<br />تحدث مع طبيبك أو الصيدلي قبل أخذ الدواء:<br />&bull; إن عانيت في الماضي من انخفاض حاد بضغط الدم أثناء أخذ أحد كوابح بيتا ( قد يتضمن ذلك الاستعمال<br />السابق لألفوزوسين). انظر الفقرة أعلاه على الفور لمعرفة أمثلة لكابحات ألفا الأخرى.<br />&bull; إن كنت تأخذ دواءً لعلاج ارتفاع ضغط الدم، فقد تشعر بالدوخة أو الضعف أو تبدأ في التعرق خلال<br />ساعات قليلة من أخذ هذا الدواء. وفي حالة حدوث ذلك، استلقي حتد تذهب الأعراض تمامًا، وأعلم<br />طبيبك، فقد تتغير جرعة دوائك.<br />&bull; إن كنت تأخذ أدوية لعلاج ألم الصدر أو الذبحة (النترات).<br />&bull; إن كنت تأخذ أدوية للعدوات الفطرية ( مثل كيتوكونازول، إيتراكونازول).<br />&bull; إن كنت تأخذ أدوية لفيروس نقص المناعة البشرية ( مثل ريتونافير).<br />&bull; إن كنت تأخذ أدوية للعدوات البكتيرية ( مثل كلاريثرومايسين، تيليثرومايسين).<br />&bull; إن كنت تأخذ أدوية لعلاج الاكتئاب ( مثل نيفازودون).<br /><strong>العمليات أثناء أخذ هاي آلفا إس آر</strong><br />&bull; إن كنت ستجري عملية تحتاج لمخدر عام، أعلم الطبيب أنك تأخذ هاي آلفا إس آر قبل العملية. ذلك لأنه<br />قد يكون خطيرًا، فقد يُخفض من ضغط الدم.<br />&bull; إن كنت على وشك إجراء جراحة بالعين نتيجة الساد ( إعتام عدسة العين)، من فضلك أعلم أخصائي<br />العيون قبل الجراحة بأنك تأخذ هاي آلفا إس آر، أو أخذته من قبل. هذا لأن هاي آلفا إس آر قد يتسبب في<br />حدوث مضاعفات أثناء الجراحة، والتي يمكن التحكم بها إذا كان المتخصص على علم بذلك.<br /><strong>هاي آلفا إس آر مع الطعام والشراب والكحول</strong><br />&minus; خذ هاي آلفا إس آر بعد الطعام.<br /><strong>الحمل والرضاعة الطبيعية والخصوبة</strong><br />نظرًا لعدم استخدام هاي آلفا إس آر مع النساء، فإن هذا القسم لا ينطبق.<br /><strong>القيادة واستخدام الآلات</strong><br />قد تشعر بالدوخة والضعف أثناء أخذ هاي آلفا إس آر. وقد تحدث تفاعلات سلبية مثل الدوخة والوهن، خاصة<br />عند بدء العلاج. فإذا حدث ذلك، لا تقم بالقيادة أو استعمال أي أدوات أو آلات،</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>خذ هذا الدواء دائمًا كما أخبرك طبيبك أو الصيدلي بالضبط، وتحقق من طبيبك أو الصيدلي إن لم تكن متأكدًا.<br />&bull; ابتلع الأقراص كاملة مع وفرة من السوائل (مثل كوب من الماء).<br />&bull; لا تكسر الأقراص أو تطحنها أو تمضغها؛ فقد يؤثر ذلك على إفراز الدواء للجسم.<br />&bull; خذ هذا الدواء بعد الطعام.<br />&bull; يجب أخذ الجرعة الأولى وقت النوم.<br /><u>الاستخدام في الأطفال</u><br />لا يوصى باستعمال هاي آلفا إس آر مع الأطفال.<br /><u>البالغون:</u><br />الجرعة المعتادة هي قرص واحد 10 مجم من هاي آلفا إس آر ذو الإفراز المستدام مرة واحدة يوميًا.<br /><u>المرضى كبار السن (&lt; 65 عامًا):</u><br />الجرعة المعتادة هي قرص واحد 10 مجم من هاي آلفا إس آر ذو الإفراز الممتد مرة واحدة يوميًا. لا حاجة<br />لتعديل الجرعة مع كبار السن ( الأكبر من 65 عامًا).<br /><u>المرضى الذين يعانون من مشاكل كلوية بسيطة إلى متوسطة</u><br />لا حاجة لتعديل الجرعة مع المشاكل الكلوية البسيطة إلى المتوسطة.<br /><strong>إذا أخذت أكثر مما يجب من هاي آلفا إس آر</strong><br />اتصل بالطبيب أو بقسم الحوادث والطوارئ بالمستشفى المحلي على الفور. وأعلم الطبيب بعدد الأقراص التي<br />أخذتها. استلقِ أطول مدة ممكنة للمساعدة في إيقاف الآثار الجانبية، ولا تحاول القيادة للمستشفى بنفسك.<br /><strong>إذا نسيت أخذ هاي آلفا إس آر</strong><br />لا تأخذ جرعة مزدوجة للتعويض عن الجرعة المنسية، فقط تجاوز الجرعة المنسية وخذ القرص التالي وفقًا للجدول.<br /><strong>إذا توقفت عن أخذ هاي آلفا إس آر</strong><br />استمر في أخذ الأقراص، حتى إن تحسنت الأعراض. توقف فقط إذا طلب منك الطبيب ذلك. يُمكن<br />التحكم في الأعراض بصورة أفضل إن استمررت في أخذ نفس الجرعة من هذا الدواء.<br />تحدث مع طبيبك أو الصيدلي إن كانت لديك أي أسئلة إضافية حول استخدام هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، قد يتسبب هذا الدواء بآثار جانبية، بالرغم من عدم إصابة الجميع بها.<br /><strong>ألم بالصدر(ذبحة)</strong><br />في المعتاد، يحدث ذلك فقط إن كنت أُصبت بذبحة صدرية من قبل. إن عانيت من ألم بالصدر، توقف عن أخذ<br />الأقراص وتواصل مع الطبيب أو اذهب للمستشفى على الفور. يحدث هذا مع أقل من 1 لكل 10,000<br />شخص.<br /><strong>التفاعلات التحسسية</strong><br />قد تلاحظ أعراض الوذمة الوعائية، مثل الطفح الجلدي الأحمر المتكتل، التورم ( في جفنا العينين والوجه<br />والشفتين والفم واللسان)، صعوبة التنفس أو البلع.<br />هذه هي أعراض التفاعل التحسسي.<br />في حالة حدوث ذلك، توقف عن أخذ الأقراص وتواصل مع الطبيب أو اذهب للمستشفى على الفور. يحدث<br />هذا مع أقل من 1 لكل 10,000 شخص.<br /><strong>تشتمل الآثار الجانبية الأخرى على:<br />شائعة (قد تؤثر على 1 لكل 10 أشخاص)</strong><br />&bull; شعور بالدوخة<br />&bull; صداع<br />&bull; شعور بالإعياء (غثيان)<br />&bull; ألم بالمعدة<br />&bull; ضعف أو إرهاق<br /><strong>غير شائعة (قد تؤثر على 1 لكل 100 شخص)</strong><br />&bull; شعور بالدوخة أو الصداع أو الإغماء عند الوقوف أو الجلوس بسرعة.<br />&bull; ضربات قلب سريعة ) تسرع القلب(<br />&bull; ألم بالصدر<br />&bull; سيلان الأنف والحكة والعطس وانسداد الأنف<br />&bull; إسهال<br />&bull; طفح وحكة<br />&bull; احتباس الماء ( قد يتسبب في تورم اليدين أو القدمين)<br />&bull; دفق ساخن<br /><strong>نادرة جدًا (قد تُصيب 1 لكل 10,000 شخص):</strong><br />&bull; السمية الكبدية<br /><strong>الآثار الجانبية الإضافية (التكرارية غير معلومة) التي قد تحدث:</strong><br />إن كنت تُجري عملية جراحية على عينيك بسبب الساد ( عندما تكون عدسة العين معتمة)، قد يتسع البؤبؤ<br />بصورة ضعيفة، وقد تُصبح القزحية (&nbsp;الجزء الملون من العين) مرنة أثناء العملية.<br />&bull; عدم انتظام وسرعة نبض القلب<br />&bull; انخفاض بخلايا الدم البيضاء (قلة العدلات). قد تتضمن العلامات حدوث عدوات متكررة أو تقرح بالحلق<br />أو قرح بالفم.<br />&bull; زيادة خطر حدوث النزف ( بما في ذلك نزف الأنف و/أو نزيف اللثة ) والكدمات. قد يُشكل ذلك مشكلة<br />بالدم تُسمى &quot;قلة الصفيحات&quot;، وتعني انخفاض عدد الصفيحات بالدم.<br />&bull; شذوذ وظائف الكبد ) مشكلة كبدية(. قد تتضمن العلامات حدوث اصفرار بالجلد أو الجزء الأبيض من<br />العينين.<br />&bull; إن كنت تُجري عملية جراحية على عينيك بسبب الساد ) إعتام عدسات العينين(، وكنت تستخدم أو<br />استخدمت من قبل زوكيك، قد يتسع البؤبؤ بصورة ضعيفة، وقد تُصبح القزحية ( الجزء الملون من العين )<br />مرنة أثناء العملية. يحدث ذلك فقط أثناء العملية، ومن المهم أن يكون طبيب العيون على علم بهذه<br />الاحتمالية، فقد تكون هناك حاجة لإجراء العملية بطريقة مختلفة.<br />&bull; انتصاب مستمر غير طبيعي، وغالبًا مؤلم، بالقضيب لا يتعلق بالنشاط الجنسي ( قساح).<br />&bull; إعياء ( قيء)<br /><strong>الإبلاغ عن الآثار الجانبية</strong><br />إذا أصبت بأي آثار جانبية، تواصل مع طبيبك أو الصيدلي. ويتضمن ذلك أي آثار جانبية محتملة غير مدرجة<br />بهذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li>ابق هذا الدواء بعيدا عن نظر الأطفال ومتناول أيديهم.</li><li>لا تستخدم هذا الدواء بعد تاريخ الانتهاء المذكور على المُلصق والكرتون والزجاجة بعد&nbsp;(EXP) يُشير تاريخ انتهاء الصلاحية إلى آخر يوم بذلك الشهر.</li><li>يُحفظ في درجة حرارة أقل من 30 درجة مئوية.</li><li>لا تتخلص من أي أدوية عن طريق الصرف الصحي أو النفايات المنزلية، واسأل الصيدلي عن كيفية التخلص</li><li>من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد في حماية البيئة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي ألفوزوسين هيدروكلوريد.<br />يحتوي كل قرص مغلف ذو إفراز مستدام على ألفوزوسين هيدروكلوريد وفقًا للفارماكوبيا الأوروبية مقداره<br />10 مجم.<br />المكونات الأخرى هي:<br /><strong>جسم القرص</strong>: هيبروميلوز&nbsp; (ميثوسيل K100 MCR),زيت نباتي مهدرج، بوفيدون، فوسفات كالسيوم ،&nbsp;<br />هيدروجينية لا مائية، كاربومير، سيليكا غروية لا مائية، ستيرات ماغنسيوم.<br /><strong>غلاف القرص:</strong><br />هيبروميلوز ( ميثوسيل E5 LV&nbsp;) . بروبيلين جليكول، ثاني أكسيد التيتانيوم، ماء مُقطر. ،</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص مغلفة مستديرة ثنائية التحدب لونها أبيض إلى أبيض معتم. محفور على أحد جانبيها&nbsp;&rdquo;X&ldquo; و &quot;47&quot;على الجانب الآخر.<br />تُورد أقراص هاي آلفا إس آر في عبوة تحتوي على 30 قرص( 3 أشرطة يحتوي كل منها على 10 اقراص )</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>المُصنع:</strong><br />أوروبيندو فارما المحدودة ، الهند.<br /><strong>حامل ترخيص التسويق:</strong><br />أوروبيندو فارما السعودية المحدودة،<br />جدة، المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            02.2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hi-Alfa SR (Alfuzosin Hydrochloride Prolonged Release Tablets10 mg)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each prolonged release tablet contains Alfuzosin Hydrochloride Ph.Eur. 10 mg
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Alfuzosin Hydrochloride Prolonged Release Tablets 10 mg:White to off-white, round, biconvex, film-coated tablets, debossed with ‘X’ on one side and ‘47’ on other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Treatment of the functional symptoms of benign prostatic hypertrophy (BPH).</p><p dir="ltr">Adjunctive therapy with urethral catheterisation for Acute Urinary Retention related to BPH.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Oral use.</p><p dir="ltr">The prolonged-release tablet should be taken whole with sufficient amount of fluid (e.g. a glass of water). The prolonged-release tablets must not be crushed, chewed or divided (see section 4.4).</p><p dir="ltr">The first dose should be taken at bedtime. The prolonged-release tablet 10 mg should be taken immediately after the same meal each day.</p><p dir="ltr">Adults:</p><p dir="ltr">The recommended dose is one 10 mg prolonged-release tablet daily. Elderly (over the age of 65 years)</p><p dir="ltr">The recommended dose is the same as that for adults. Pharmacokinetic and clinical safety studies have shown that dose adjustment is not necessary in the case of elderly patients.</p><p dir="ltr">Impaired renal function</p><p dir="ltr">&nbsp;</p><p dir="ltr">Mild to moderate renal insufficiency (creatinine clearance &gt; 30 ml/min): Dose reduction is usually not necessary (see section 5.2).</p><p dir="ltr"><em>Severe renal insufficiency</em></p><p dir="ltr">Alfuzosin Tablets 10 mg should not be given to patients with severely impaired renal function (creatinine clearance &lt; 30 ml/min) as there are no clinical safety data available for this patient group (see section 4.4).</p><p dir="ltr"><em>Hepatic insufficiency:</em></p><p dir="ltr">Alfuzosin, given as 10 mg prolonged-release tablets are contraindicated in patients with hepatic insufficiency. Preparations containing a low dose of alfuzosin hydrochloride might be used in patients with mild to moderate hepatic insufficiency as instructed in the corresponding product information.</p><p dir="ltr"><em>Paediatric population:</em></p><p dir="ltr">Efficacy of alfuzosin has not been demonstrated on children aged 2 to 16 years (see section 5.1). Therefore, alfuzosin is not indicated for use in paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the alfuzosin hydrochloride other quinazolines (e.g. terazosine, doxazosine) or to any of the excipients listed in section 6.1
•	Previous history of orthostatic hypotension;
•	Liver insufficiency
•	Combination with other alpha 1- blockers
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Alfuzosin 10 mg tablets should not be given to patients with severe renal impairment (creatinine clearance &lt; 30 ml/min) in view of the lack of clinical safety data in this group of patients.</p><p dir="ltr">Alfuzosin should be given with caution to patients who are on antihypertensive medication or nitrates.</p><p dir="ltr">In some subjects postural hypotension may develop, with or without symptoms (dizziness, fatigue, sweating) within a few hours following administration. In such cases, the patient should lie down until the symptoms have completely disappeared.</p><p dir="ltr">These effects are usually transient, occur in the beginning of treatment and do not usually prevent the continuation of treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Pronounced drop in blood pressure has been reported in post-marketing surveillance in patients with pre-existing risk factors (such as underlying cardiac diseases and/or concomitant treatment with anti-hypertensive medication). The risk of developing hypotension and related adverse reactions may be greater in elderly patients.</p><p dir="ltr">Care should be taken when alfuzosin is administered to patients who have had a pronounced hypotensive response to another alpha1-blocker.</p><p dir="ltr">In coronary patients, the specific treatment for coronary insufficiency should be continued. If angina pectoris reappears or worsens, alfuzosin should be discontinued.</p><p dir="ltr">As with all alpha-1-blockers, alfuzosin should be used with caution in patients with acute cardiac failure.</p><p dir="ltr">Patients with congenital QTc prolongation, with a known history of acquired QTc prolongation or who are taking drugs known to increase the QTc interval should be evaluated before and during the administration of alfuzosin</p><p dir="ltr">Concomitant use of alfuzosin and potent CYP3A4 inhibitors (such as itraconazole, ketoconazole, protease inhibitors,clarithromycin, telithromycin and nefazodone) should be avoided (see section 4.5). Alfuzosin should not be used concomitantly with CYP3A4 inhibitors that are known to increase the QTc interval (e.g. itraconazole and clarithromycin)and a temporary interruption of alfuzosin treatment is recommended if treatment with such medicinal products is initiated.</p><p dir="ltr">The &#39;Interoperative Floppy Iris Syndrome&#39; (IFIS, a variant of small pupil syndrome) has been observed during cataract surgery in some patients on or previously treated with tamsulosin. Isolated reports have also been received with otheralpha-1 blockers and the possibility of a class effect cannot be excluded. As IFIS may lead to increased procedural complications during the cataract operation, current or past use of alpha-1 blockers should be made known to the opthalmic surgeon in advance of surgery.</p><p dir="ltr">Alfuzosin, like other alpha adrenergic antagonist, has been associated with priapism (persistent painful penile erectionunrelated to sexual activity; see section 4.8). Because this condition can lead to permanent impotence if not properly treated, patients should be advised to seek immediate assistance in the event of an erection that persists longer than 4hours.</p><p dir="ltr">Patients should be warned that the tablet should be swallowed whole. Any other mode of administration, such as crunching, crushing, chewing, grinding or pounding to powder should be prohibited.</p><p dir="ltr">These actions may lead to inappropriate release and absorption of the drug and therefore possible early adverse reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No pharmacodynamic or pharmacokinetic interactions have been observed in studies with healthy volunteers between alfuzosin and the following drugs:</p><p dir="ltr">warfarin, digoxin, hydrochlorothiazide and atenolol.</p><p dir="ltr">Administration of general anaesthetics to a patient treated with alfuzosin may lead to blood pressure instability.</p><p dir="ltr">Combinations contra-indiacted</p><p dir="ltr">-&nbsp; Alpha-1 receptor blockers (see section 4.3)</p><p dir="ltr">Increased hypotensive effect. Risk of severe orthostatic hypotension. Concomitant use not recommended:</p><p dir="ltr">-&nbsp;&nbsp;Potent CYP3A4 inhibitors such as itraconazole, ketoconazole, protease inhibitors, clarithromycin, telithromycin and nefazodone since alfuzosin blood levels may be increased (see section 4.4)</p><p dir="ltr">Combinations to be taken into account</p><p dir="ltr">-&nbsp; Antihypertensive drugs (see section 4.4)</p><p dir="ltr">-&nbsp; Nitrates (see section 4.4)</p><p dir="ltr">Ketoconazole: Repeated 200 mg daily dosing of ketoconazole, for seven days resulted in a 2.1 fold increase in Cmax and a 2.5 fold increase in exposure of alfuzosin 10 mg OD when administered under fed conditions. Other parameters such as tmax and t1/2 were not modified.</p><p dir="ltr">The increase in alfuzosin Cmax and AUC following repeated 400 mg daily administration of ketoconazole was 2.3-fold, and 3.2-fold , respectively (see section5.2).</p><p dir="ltr">See also section 4.4.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Due to the type of indication this section is not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">There are no data available on the effect on driving vehicles.</p><p dir="ltr">Adverse reactions such as dizziness and asthenia may occur essentially at the beginning of treatment. This has to be taken into consideration when driving vehicles and operating machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Classification of expected frequencies:</p><p dir="ltr">Very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:672px"><tbody><tr><td colspan="4" style="vertical-align:top"><p><strong>Frequency</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>body organ system&nbsp;</strong></p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>&nbsp;Not Known &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Very rare&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Uncommon&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Common&nbsp; &nbsp; &nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Neutropenia, thrombocytope</p></td><td style="vertical-align:top"><p>Blood and lymphatic system</p></td></tr><tr><td style="vertical-align:top"><p>Dizziness, headache</p></td><td style="vertical-align:top"><p>Syncope, Vertigo</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Nervous</p><p>system disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Intraoperative floppy iris syndrome</p></td><td style="vertical-align:top"><p>Eye disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Tachycardia</p></td><td style="vertical-align:top"><p>Angina pectoris in patients with pre- existing coronary artery disease (see section 4.4)</p></td><td style="vertical-align:top"><p>Atrial fibrillation</p></td><td style="vertical-align:top"><p>Cardiac disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypotension (postural), flushing</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Vascular disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rhinitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Respiratory, thoracic and</p><p>mediastinal</p></td></tr><tr><td style="vertical-align:top"><p>Nausea, abdominal pain</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Gastrointestin al disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>hepatotoxicity</p></td><td style="vertical-align:top"><p>Hepatocellular injury, cholestatic</p></td><td style="vertical-align:top"><p>Hepatobiliy disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash, pruritus</p></td><td style="vertical-align:top"><p>Urticaria, angioedema</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Skin and</p><p>subcutaneous tissue disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Priapism</p></td><td style="vertical-align:top"><p>Reproductive system and breast</p></td></tr><tr><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>Oedema, chest pain</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>General disorders and administration</p><p>site conditionsb</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p dir="ltr">To&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; report&nbsp;&nbsp;&nbsp; any&nbsp;&nbsp;&nbsp; side effect(s):</p><p dir="ltr"><em>Saudi Arabia:</em></p><p dir="ltr">The National Pharmacovigilance Center (NPC)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: <u>https://ade.sfda.gov.sa/</u></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In case of overdosage, the patient should be hospitalised, kept in the supine position, and conventional treatment of hypotension should take place.</p><p dir="ltr">In case of significant hypotension, the appropriate corrective treatment may be a vasoconstrictor that acts directly on vascular muscle fibres.</p><p dir="ltr">Alfuzosin is highly protein-bound, therefore, dialysis may not be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic category: alpha-adrenoreceptor antagonists. ATC code: G04C A01 Alfuzosin</p><p dir="ltr"><u>Mechanism of action</u></p><p dir="ltr">Alfuzosin, a racemic compound, is an orally active quinazoline derivative that selectively blocks post-synaptic alpha-l-receptors.In vitro studies have shown that the substance acts selectively on alpha-1-receptors in the trigone of the urinebladder, the urethra and the prostate gland. The clinical symptoms of benign prostate hyperplasia are not only related tothe size of the prostate but also to the sympathicomimetic nerve impulses which through stimulation of the postsynapticalpha-receptors increase the tension of the smooth muscles of the lower urinary tract. Through treatment with alfuzosinthe smooth muscles relax as a result of which the urine flow improves.</p><p dir="ltr">The clinical evidence of the selective effect on the urinary tract is shown by the clinical efficacy and the good safetyprofile in men treated with alfuzosin, including elderly patients and patients with hypertension. Alfuzosin can result inmoderate antihypertensive effects.</p><p dir="ltr">In men, alfuzosin improves the voiding of water by reducing urethral muscle tone and bladder outlet resistance, therebyfacilitating bladder emptying.</p><p dir="ltr">In patients treated with alfuzosin a lower frequency of acute urine retention was observed than in untreated patients.</p><p dir="ltr">In placebo-controlled studies in patients with benign prostate hyperplasia alfuzosin:</p><p dir="ltr">-&nbsp; significantly increased maximum urine flow (Qmax) in patients with Qmax &lt;15 ml/sec by an average of 30%. This improvement was observed from the first dose;</p><p dir="ltr">-&nbsp; a significantly reduced detrusor pressure and an increased volume, producing a strong desire to void,</p><p dir="ltr">-&nbsp; a significantly reduced the residual urine volume.</p><p dir="ltr">These urodynamic effects result in an improvement in lower urinary tract symptoms (LUTS), i.e. symptoms relating toretention (irritating) and urine discharge (obstructive) which is clearly demonstrated.</p><p dir="ltr"><em>Paediatric population</em></p><p dir="ltr">Alfuzosin is not indicated for use in the paediatric population (see section 4.2).</p><p dir="ltr">Efficacy of alfuzosin hydrochloride was not demonstrated in the two studies conducted in 197 patients 2 to 16 years ofage with elevated detrusor leak point pressure (LPP&ge;40 cm H2O) of neurologic origin. Patients were treated withalfuzosin hydrochloride 0.1 mg/kg/day or 0.2 mg/kg/day using adapted paediatric formulations.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Alfuzosin has linear pharmacokinetics in the therapeutic dosage range. The kinetic profile is characterised by large inter-individual fluctuations in the plasma concentration. Absorption is increased when the medication is administered after a meal.</p><p dir="ltr"><em>Absorption</em></p><p dir="ltr">After the first dose (following a meal) the mean maximum plasma concentration was 7.72 ng/ml and the AUCinf 127 ng x h/ml (after a meal) and the tmax was 6.69 hours (after a meal).</p><p dir="ltr">In steady state conditions (after a meal) the mean AUC over the dosage interval (AUC&tau;) was 145 ng x h/ml, the mean Cmax 10.6 ng/ml and Cmin was 3.23 ng/ml.</p><p dir="ltr"><em>Distribution</em></p><p dir="ltr">Plasma protein binding is approx. 90%. The distribution volume of alfuzosin in healthy test subjects is 2.5 l/kg. It has been shown that the substance is distributed more in the prostate than in the plasma.</p><p dir="ltr"><em>Elimination</em></p><p dir="ltr">The apparent elimination half-life is approximately 8 hours. Alfuzosin is largely metabolised in the liver (various routes), the metabolites are eliminated by the kidneys and probably also via the bile, 75-91% of an oral dose is eliminated in the faeces, 35% in unmodified form and the rest as metabolites, which indicates that some excretion via the bile takes place. Around 10% of the dose is eliminated in unmodified form in the urine. None of the metabolites are pharmacologically active.</p><p dir="ltr"><em>Renal or hepatic impairment</em></p><p dir="ltr">The volume of distribution and clearance increases with reduced renal function, possibly owing to a decreased degree of protein binding. The half-life, however, is unchanged. This change in the pharmacokinetic profile is not considered clinically relevant. Therefore, this does not necessitate a dosing adjustment in patients with mild to moderate renal insufficiency.</p><p dir="ltr">The half-life is prolonged in patients with severe hepatic insufficiency. The peak plasma concentration is doubled and the bioavailability increases in relation to that in young, healthy volunteers. Alfuzosin hydrochloride prolonged release tablets 10 mg are contraindicated in hepatic insufficiency. (see sections 4.2 and 4.4).</p><p dir="ltr"><em>Elderly patients</em></p><p dir="ltr">Compared to healthy middle-aged volunteers, the peak plasma concentration (Cmax) and bioavailability (AUC) are not increased in elderly patients. The elimination half-life (t&frac12;) remains unchanged.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pre-clinical data reveal no special hazard for humans based on conventional studies of genotoxicity, carcinogenicpotential or reproductive toxicity for males.</p><p dir="ltr">In vitro,alfuzosin prolonged the action potential duration and QT intervalduration at a clinically relevant concentration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Tablet core: </strong>Hypromellose (Methocel K100 MCR), Hydrogenated Vegetable Oil, Povidone, Calcium Hydrogen Phosphate, Anhydrous, Carbomer, Silica Colloidal Anhydrous, Magnesium stearate.</p><p dir="ltr">Tablet coating:</p><p dir="ltr">Hypromellose (Methocel E5 LV), Propylene Glycol, Titanium Dioxide and Purified Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Store below 30<sup>0</sup>C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Blister pack</p><p dir="ltr">Hi-alfa SR 10 mg are supplied in 30&rsquo;s pack (10&rsquo;s Blister x 3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aurobindo Pharma Saudi Arabia Limited, Jeddah, Saudi Arabia.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2022.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>